Skip to content
Sunday, November 22, 2026Independent education · Evidence in contextOur standards
MedicalGenetics.Science for life. Knowledge for care.
HomeGenetics toolsSource watchEveryday geneticsClinical practiceFor researchersArticle libraryTrusted resources
HomeAuthorsMedical Genetics editorial team

Articles by Medical Genetics editorial team

A target and an outcome measure represent choosing a clinical endpoint rather than relying only on a laboratory signal.
Clinical research

Rare-disease trial endpoints: measure a change that matters

October 22, 2026 Medical Genetics editorial team Comments Off on Rare-disease trial endpoints: measure a change that matters
Small populations make endpoint selection more demanding, not less; connect measurement quality, natural history and patient relevance.

[…]

A treatment marker and a clock illustrate the need to assess benefit and safety over time, not a promised duration.
Gene & cell therapies

How long does gene therapy last? Reading durability evidence

October 22, 2026 Medical Genetics editorial team Comments Off on How long does gene therapy last? Reading durability evidence
Assess long-term gene-therapy results using clinical outcomes, follow-up duration, missing data and additional treatments. Includes a reading worksheet.

[…]

Two linked records and a small lock represent useful data sharing with controlled access.
Research ethics & data

Rare-disease data sharing: make data useful without treating access as unlimited

October 22, 2026 Medical Genetics editorial team Comments Off on Rare-disease data sharing: make data useful without treating access as unlimited
FAIR principles and responsible governance can support discovery while preserving consent, privacy and accountability.

[…]

A highlighted association region spans several possible genes, illustrating why the nearest gene is not automatically causal.
Complex disease genetics

From GWAS signal to mechanism: why the nearest gene is not the answer

October 22, 2026 Medical Genetics editorial team Comments Off on From GWAS signal to mechanism: why the nearest gene is not the answer
Association identifies a genomic neighborhood; causal variants, target genes and biological effects require additional evidence.

[…]

A schematic gene branches toward two distinct disease contexts. Gene–disease evidence must match the disease and inheritance mechanism. Gene X and the two disease symbols are fictional teaching placeholders, not curated clinical relationships.
Gene discovery

Gene–disease validity: establish the association before classifying a candidate

October 22, 2026 Medical Genetics editorial team Comments Off on Gene–disease validity: establish the association before classifying a candidate
Assess a gene–disease claim before interpreting a variant: practical examples, evidence checks and current ClinGen guidance.

[…]

Two differently annotated reports represent conflicting classifications that require comparison of evidence, dates and conditions.
Variant interpretation

Conflicting ClinVar classifications: how to read the evidence

October 22, 2026 Medical Genetics editorial team Comments Off on Conflicting ClinVar classifications: how to read the evidence
A practical guide to comparing ClinVar submissions, reading review stars and preparing a focused question for the reporting laboratory. Includes a fictional worked example and a six-step worksheet.

[…]

Three illustrative groups of allele markers emphasize population context. Marker counts are not population frequencies.
Population genetics

Population reference datasets: rarity, constraint and ancestry in context

October 22, 2026 Medical Genetics editorial team Comments Off on Population reference datasets: rarity, constraint and ancestry in context
Reference databases are essential for variant interpretation, but absence, group labels and gene-level constraint each require careful qualification.

[…]

A report connected to a clinical decision symbol represents actionability requiring both evidence and a useful care response.
Genomic testing

What makes a genetic result clinically actionable?

October 22, 2026 Medical Genetics editorial team Comments Off on What makes a genetic result clinically actionable?
Finding a DNA change is only part of the question. Clinical actionability asks whether reliable evidence supports a useful response to that finding.

[…]

Two similar sequence segments include a distinguishing base marker, illustrating assay discrimination.
Genomic testing

Pseudogene interference: establish which DNA your assay measured

October 22, 2026 Medical Genetics editorial team Comments Off on Pseudogene interference: establish which DNA your assay measured
CYP21A2 illustrates how similar DNA sequences and complex gene structures challenge genetic analysis—and why research methods need locus-specific validation.

[…]

Posts pagination

« 1 … 12 13

Recent Posts

  • Personalised base editing: what an individual-patient result can show
  • Newborn genome screening: benefits, limits and follow-up
  • 22q11.2 deletion syndrome: one genetic diagnosis, different health needs
  • X-linked hypophosphatemia: connect phosphate loss with PHEX testing
  • TTR T60A (Thr80Ala): what the variant name means

Recent Comments

No comments to show.
Medical Genetics

Clear explanations. Traceable evidence. A thoughtful view of genetics across everyday life, clinical care and research.

Publisher & medical editor: Saeed Reza Ghaffari, MD, MSc, PhD
Medical Genetics Specialist · About the publisher

Learning resourcesTrusted resourcesSource watchAboutEditorial policyPrivacyContact
© 2026 Medical Genetics. Educational information, not individual medical advice. Article review status and sources are shown separately. No affiliation with similarly named journals or professional societies is implied.